Staci Sabnis

This inventor holds 16 USPTO granted patents and 13 published patent applications and 7 EPO patents. Top assignees: Modernatx, Inc., Fundacion Para La Investigacion Medica Aplicada, Oregon State University. Active years: 2018-2025.

USPTO Granted Patents = 16 (Patent Applications = 13)

% Patents Active = 100.0

EPO Patents = 7 (Patent Applications = 11)

Average Co-Inventor Count = 6.7

ph-index = 5

Forward Citations = 153(Granted Patents)

Location History:

Somerville, MA (US) (2018 - 2019)
Cambridge, MA (US) (2019 - 2024)

Company Filing History:

Fundacion Para La Investigacion Medica Aplicada

patents

1 out of 328

Oregon State University

patents

4. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12491260 - COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS (2025-12-09),

2. 12377136 - Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyria (2025-08-05),

3. 12252704 - Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1 (2025-03-18),

4. 12239742 - Polynucleotides encoding Citrin for the treatment of Citrullinemia type 2 (2025-03-04),

5. 11969506 - Lipid nanoparticle formulation (2024-04-30),

6. 11649461 - Polynucleotides encoding α-galactosidase A for the treatment of Fabry disease (2023-05-16),

7. 11285222 - Compositions and methods for delivery of agents (2022-03-29),

8. 11001861 - Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1 (2021-05-11),

9. 10993918 - Polynucleotides encoding citrin for the treatment of Citrullinemia type 2 (2021-05-04),

10. 10556018 - Compositions and methods for delivery of agents (2020-02-11),

11. 10519455 - Polynucleotides encoding alpha-galactosidase A for the treatment of Fabry disease (2019-12-31),

12. 10494636 - Polynucleotides encoding α-galactosidase A for the treatment of Fabry disease (2019-12-03),

13. 10485885 - Compositions and methods for delivery of agents (2019-11-26),

14. 10258698 - Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions (2019-04-16),

15. 10207010 - Compositions and methods for delivery of agents (2019-02-19),

Title: The Innovative Journey of Staci Sabnis

Introduction: Staci Sabnis is a pioneering inventor based in Cambridge, MA, known for her groundbreaking contributions to various fields.

Latest Patents: Staci Sabnis holds several patents in the areas of biotechnology, medical devices, and sustainable energy solutions, showcasing her diverse range of expertise.

Career Highlights: With a background in bioengineering and a passion for creating impactful solutions, Staci Sabnis has led numerous successful projects that have revolutionized industries and improved people's lives.

Collaborations: Throughout her career, Staci Sabnis has collaborated with leading research institutions, universities, and companies to bring her innovative ideas to life, fostering a culture of creativity and progress.

Conclusion: Staci Sabnis continues to inspire with her innovative spirit and dedication to pushing the boundaries of what is possible, leaving a lasting legacy in the world of inventions and patents.